Sacral Nerve Stimulation (SNS) Devices Segment to Witness Higher CAGR During Forecast Period
According to the latest study on “Asia Pacific Electrical Stimulation Devices Market Forecast to 2027 – COVID-19 Impact and Analysis – by Device Type and Application,” the market was valued at US$ 1,195.6 million in 2019 and is projected to reach US$ 2,506.0 million by 2027; it is expected to grow at a CAGR of 9.9% during 2020–2027. The report highlights trends prevailing in the Asia Pacific electrical stimulation devices market and the factors driving market along with those that act as hindrances.
Based on device type, the Asia Pacific electrical stimulation devices market is segmented into spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation (VNS) devices, sacral nerve stimulation (SNS) devices, gastric electrical stimulation (GES) Devices, transcutaneous electrical nerve stimulation (TENS) devices, and other devices. In 2019, the spinal cord devices segment held a larger share of the market. However, the sacral nerve stimulation devices segment is expected to grow at a faster rate during the forecast period.
The growth of the Asia Pacific electrical stimulation devices market is attributed to the increasing incidences of neurological disorders, growing prevalence of chronic pain, and increasing product awareness. However, the high cost of procedures limits the growth of market in this region.
Boston Scientific Corporation, Medtronic, Abbott, BTL, and DJO Global Inc. are among the leading companies operating in the Asia Pacific electrical stimulation devices market.
Asia Pacific Electrical Stimulation Devices Market, By Region, 2019 (%)
Asia Pacific Electrical Stimulation Devices Market to Grow at a CAGR of 9.9% to reach US$ 2,506.0 Million from 2020 to 2027
Download Free Sample
Asia Pacific Electrical Stimulation Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electrical Stimulation (GES) Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, and Other Devices ); Application ( Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism and GIT Management, Incontinence Management, and Other Application ), and Country
Asia Pacific Electrical Stimulation Devices Market to Grow at a CAGR of 9.9% to reach US$ 2,506.0 Million from 2020 to 2027
Download Free SampleAsia Pacific Electrical Stimulation Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electrical Stimulation (GES) Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, and Other Devices ); Application ( Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism and GIT Management, Incontinence Management, and Other Application ), and Country
The report segments Asia Pacific Electrical Stimulation Devices Market as follows:
By Device Type
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Vagus Nerve Stimulation (VNS) Devices
- Sacral Nerve Stimulation (SNS) Devices
- Gastric Electrical Stimulation (GES) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Other Devices
By Application
- Pain Management
- Neurological and Movement Disorder Management
- Musculoskeletal Disorder Management
- Metabolism and GIT Management
- Incontinence Management
- Other Applications
By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific